Patrick J Heron - Net Worth and Insider Trading

Patrick J Heron Net Worth

The estimated net worth of Patrick J Heron is at least $514 Million dollars as of 2024-06-15. Patrick J Heron is the Director of Vaxcyte Inc and owns about 2,309,554 shares of Vaxcyte Inc (PCVX) stock worth over $168 Million. Patrick J Heron is the Director of Imago BioSciences Inc and owns about 2,971,274 shares of Imago BioSciences Inc (IMGO) stock worth over $107 Million. Patrick J Heron is also the Director of Mirum Pharmaceuticals Inc and owns about 3,728,875 shares of Mirum Pharmaceuticals Inc (MIRM) stock worth over $97 Million. Besides these, Patrick J Heron also holds Arcutis Biotherapeutics Inc (ARQT) , Collegium Pharmaceutical Inc (COLL) , Passage Bio Inc (PASG) , Cidara Therapeutics Inc (CDTX) , Iterum Therapeutics PLC (ITRM) . Details can be seen in Patrick J Heron's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Patrick J Heron has not made any transactions after 2024-03-04 and currently still holds the listed stock(s).

Transaction Summary of Patrick J Heron

To

Patrick J Heron Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Patrick J Heron owns 20 companies in total, including Tarsus Pharmaceuticals Inc (TARS) , Iterum Therapeutics PLC (ITRM) , and Vaxcyte Inc (PCVX) among others .

Click here to see the complete history of Patrick J Heron’s form 4 insider trades.

Insider Ownership Summary of Patrick J Heron

Ticker Comapny Transaction Date Type of Owner
TARS Tarsus Pharmaceuticals Inc 2020-10-15 10 percent owner
ITRM Iterum Therapeutics PLC 2019-05-24 director & 10 percent owner
PCVX Vaxcyte Inc 2020-06-16 director
LIMIT LIMIT 2019-10-24 10 percent owner
LIMIT LIMIT 2023-11-09 director & 10 percent owner
LIMIT LIMIT 2020-03-03 director & 10 percent owner
LIMIT LIMIT 2024-03-04 director & 10 percent owner
LIMIT LIMIT 2018-09-25 10 percent owner
LIMIT LIMIT 2017-07-24 10 percent owner
LIMIT LIMIT 2018-06-20 10 percent owner
LIMIT LIMIT 2017-01-25 10 percent owner
LIMIT LIMIT 2017-02-14 10 percent owner
LIMIT LIMIT 2016-11-01 director
LIMIT LIMIT 2015-05-12 director & 10 percent owner
LIMIT LIMIT 2015-06-24 10 percent owner
LIMIT LIMIT 2015-04-20 director
LIMIT LIMIT 2021-07-20 director
LIMIT LIMIT 2020-12-08 director
LIMIT LIMIT 2022-04-28 director & 10 percent owner
LIMIT LIMIT 2020-12-08 director

Patrick J Heron Latest Holdings Summary

Patrick J Heron currently owns a total of 8 stocks. Among these stocks, Patrick J Heron owns 2,309,554 shares of Vaxcyte Inc (PCVX) as of June 16, 2020, with a value of $168 Million and a weighting of 32.79%. Patrick J Heron owns 2,971,274 shares of Imago BioSciences Inc (IMGO) as of July 20, 2021, with a value of $107 Million and a weighting of 20.83%. Patrick J Heron also owns 3,728,875 shares of Mirum Pharmaceuticals Inc (MIRM) as of November 9, 2023, with a value of $97 Million and a weighting of 18.81%. The other 5 stocks Arcutis Biotherapeutics Inc (ARQT) , Collegium Pharmaceutical Inc (COLL) , Passage Bio Inc (PASG) , Cidara Therapeutics Inc (CDTX) , Iterum Therapeutics PLC (ITRM) have a combined weighting of 27.57% among all his current holdings.

Latest Holdings of Patrick J Heron

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PCVX Vaxcyte Inc 2020-06-16 2,309,554 72.94 168,458,869
IMGO Imago BioSciences Inc 2021-07-20 2,971,274 36.01 106,995,577
MIRM Mirum Pharmaceuticals Inc 2023-11-09 3,728,875 25.92 96,652,440
ARQT Arcutis Biotherapeutics Inc 2024-03-04 8,817,666 8.63 76,096,458
COLL Collegium Pharmaceutical Inc 2015-05-12 1,887,332 31.76 59,941,664
PASG Passage Bio Inc 2020-03-03 5,009,219 1.05 5,259,680
CDTX Cidara Therapeutics Inc 2015-04-20 14,551 13.44 195,565
ITRM Iterum Therapeutics PLC 2018-05-30 102,554 1.15 117,937

Holding Weightings of Patrick J Heron


Patrick J Heron Form 4 Trading Tracker

According to the SEC Form 4 filings, Patrick J Heron has made a total of 1 transactions in Vaxcyte Inc (PCVX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Vaxcyte Inc is the acquisition of 250,000 shares on June 16, 2020, which cost Patrick J Heron around $4 Million.

According to the SEC Form 4 filings, Patrick J Heron has made a total of 1 transactions in Imago BioSciences Inc (IMGO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Imago BioSciences Inc is the acquisition of 187,500 shares on July 20, 2021, which cost Patrick J Heron around $3 Million.

According to the SEC Form 4 filings, Patrick J Heron has made a total of 5 transactions in Mirum Pharmaceuticals Inc (MIRM) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in Mirum Pharmaceuticals Inc is the acquisition of 2,910 shares on November 9, 2023, which cost Patrick J Heron around $82,353.

More details on Patrick J Heron's insider transactions can be found in the Insider Trading History of Patrick J Heron table.

Insider Trading History of Patrick J Heron

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Patrick J Heron Trading Performance

GuruFocus tracks the stock performance after each of Patrick J Heron's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Patrick J Heron is 8.38%. GuruFocus also compares Patrick J Heron's trading performance to market benchmark return within the same time period. The performance of stocks bought by Patrick J Heron within 3 months outperforms 8 times out of 13 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Patrick J Heron's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Patrick J Heron

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
4 out of 8 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 3.87 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 5.58 LIMIT LIMIT LIMIT LIMIT LIMIT

Patrick J Heron Ownership Network

Ownership Network List of Patrick J Heron

No Data

Ownership Network Relation of Patrick J Heron

Insider Network Chart

Patrick J Heron Owned Company Details

What does Tarsus Pharmaceuticals Inc do?

Who are the key executives at Tarsus Pharmaceuticals Inc?

Patrick J Heron is the 10 percent owner of Tarsus Pharmaceuticals Inc. Other key executives at Tarsus Pharmaceuticals Inc include Chief Human Resources Officer Dianne C. Whitfield , General Counsel Bryan Wahl , and Chief Operating Officer Seshadri Neervannan .

Tarsus Pharmaceuticals Inc (TARS) Insider Trades Summary

Over the past 18 months, Patrick J Heron made no insider transaction in Tarsus Pharmaceuticals Inc (TARS). Other recent insider transactions involving Tarsus Pharmaceuticals Inc (TARS) include a net sale of 323,447 shares made by Bobak R. Azamian , a net sale of 14,020 shares made by Aziz Mottiwala , and a net sale of 21,966 shares made by Leonard M. Greenstein .

In summary, during the past 3 months, insiders sold 28,810 shares of Tarsus Pharmaceuticals Inc (TARS) in total and bought 0 shares, with a net sale of 28,810 shares. During the past 18 months, 403,563 shares of Tarsus Pharmaceuticals Inc (TARS) were sold and 10,506 shares were bought by its insiders, resulting in a net sale of 393,057 shares.

Tarsus Pharmaceuticals Inc (TARS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Tarsus Pharmaceuticals Inc Insider Transactions

No Available Data

Patrick J Heron Mailing Address

Above is the net worth, insider trading, and ownership report for Patrick J Heron. You might contact Patrick J Heron via mailing address: 550 Hamilton Ave., Suite 100, Palo Alto Ca 94301.

Discussions on Patrick J Heron

No discussions yet.